Samumed Competitors and Similar CompaniesClear all

AdAlta's competitors and similar companies include BioMarin Pharmaceutical.
AdAlta
AdAlta
AdAlta is a drug discovery and development company intended to generate a new class of protein therapeutics, known as i-bodies.
BioMarin Pharmaceutical
BioMarin Pharmaceutical
BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.
Founding Date
Founding Date
2006
Founding Date
1997
Type
Type
Public
Type
Public
Tags
Locations
Locations
Bundoora, AU HQ
Melbourne, AU
Locations
San Rafael, US HQ
Martínez, AR
Crows Nest, AU
Sao Paulo, BR
Bogotá, CO
Kronberg Im Taunus, DE
Wanchai, HK
see more
Employees
Employees
9
Employees
3,0015% increase
Valuation ($)
Valuation ($)
7.2 m
Valuation ($)
13.3 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$3.2b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$717.4m (FY, 2025)
Gross profit
Gross profit
$677k (FY, 2025)
Gross profit
$2.5b (FY, 2025)
Net income
Net income
($4.5m) (FY, 2025)
Net income
$348.9m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

BioMarin Pharmaceutical
HQ
San Rafael, US
Employees
3,001↑ 5% increase

BioMarin develops and provides innovative biopharmaceuticals for serious diseases and medical conditions.

View company